Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus

Mark H. Ebell

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus'. Together they form a unique fingerprint.